Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

Azaya Therapeutics, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for its lead product “ATI-1123,” a novel and improved formulation of Taxotere® (docetaxel), a leading chemotherapy drug with worldwide annual sales of over $2.8 billion.

10 Dec 2009

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. today announced financial results for the second quarter of fiscal year (FY) 2010 ended October 31, 2009. Total revenue for the second quarter of FY 2010 increased 255% to $6,896,000, compared to $1,941,000 for the comparable prior year quarter.

10 Dec 2009

Nutraceutical International reports net income of $3.2M for fourth-quarter fiscal 2009

Nutraceutical International Corporation today reported results for the fiscal 2009 fourth quarter and year ended September 30, 2009. Net sales for the fiscal 2009 fourth quarter were $41.4 million compared to $40.9 million for the same quarter of fiscal 2008.

10 Dec 2009

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Biodel Inc. today reported financial results for the fourth quarter and fiscal year ended September 30, 2009.

10 Dec 2009

Urodynamix Technologies reviews strategic alternatives for sale of company's assets

Urodynamix Technologies Ltd. today announces that its Board of Directors has initiated a process to review strategic alternatives including the sale of part of or all of the Company's assets.

10 Dec 2009

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

Pacific Beach BioSciences, Inc. today reported that it has granted non-exclusive rights to a large pharmaceutical company for the use of one of its anti-fungal compounds required for the manufacturing of a clinical stage product.

9 Dec 2009

USPTO grants CyDex Pharmaceuticals patent for Captisol

CyDex Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a patent to the company entitled “Sulfoalkyl Ether Cyclodextrin Compositions and Methods of Preparation Thereof.” This patent, along with other previously issued technology patents, will provide broader protection for CyDex’s Captisol® technology until 2028.

9 Dec 2009

Unigene Laboratories announces reduction in workforce and operating expenses

Unigene Laboratories, Inc. has announced a restructuring plan that includes a reduction in workforce to improve operational efficiencies and to better match resources with market demand and the Company’s strategic objectives.

9 Dec 2009

Nautilus enters into definitive agreements for sale of certain assets to Fit Dragon International

Fitness company Nautilus, Inc., (the “Company”) announces today that it has entered into definitive agreements for the sale of certain assets of its commercial business to Fit Dragon International Ltd.

9 Dec 2009

European market for digestive health ingredients to reach $536.5 million in 2015

rowing consumer awareness of functional foods fuels demand and boosts product availability for digestive health ingredients in the EU. In 2008, digestive health was the largest product segment of the total EU approved functional food market, accounting for 68.0 per cent of sales.

9 Dec 2009

First-quarter fiscal 2010 results announced by Helix BioPharma

Helix BioPharma Corp. today announced financial results for the first quarter ended October 31, 2009.

9 Dec 2009

Opinions: ARV access; global health promotion; climate change; under-nutrition; Ethiopia

In an Intellectual Property Watch column, Daniele Dionisio, of the Italian Network for International Fight against AIDS, examines how trade rules and policy directions by governments and institutions may help to improve countries' access to antiretrovirals.

8 Dec 2009

Market for personalized medicine in the United States to grow 11 percent annually, shows report

The market for personalized medicine in the United States is already $232 billion, and it is projected to grow 11 percent annually, according to a new report published today by PricewaterhouseCoopers LLP, entitled The Science of Personalized Medicine: Translating the Promise into Practice.

8 Dec 2009

ThermoGenesis enters into material transfer agreement with GID Group

ThermoGenesis Corp., a leading supplier of innovative products for processing and storing adult stem cells, said today it has entered into a material transfer agreement with the GID Group which has been working with ThermoGenesis to use ThermoGenesis' MarrowXpress(TM), or MXP(TM), based technology for the processing of adipose, or fatty, tissue - a rich source of adult stem cells.

8 Dec 2009

La Jolla Pharmaceutical enters into definitive merger agreement with Adamis Pharmaceuticals

La Jolla Pharmaceutical Company (“La Jolla”) today announced that it entered into a definitive merger agreement with Adamis Pharmaceuticals Corporation (“Adamis”) on December 4, 2009.

8 Dec 2009

Adamis Pharmaceuticals to acquire La Jolla Pharmaceutical Company

Adamis Pharmaceuticals Corporation (OTCBB: ADMP), announced today that it has entered into a definitive merger agreement providing for the acquisition of La Jolla Pharmaceutical Company by Adamis.

7 Dec 2009

Biolife Solutions, Centocor Research & Development sign license and cGMP manufacturing agreement

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has executed a license and custom cGMP manufacturing agreement with Centocor Research & Development, Inc.

7 Dec 2009

Sustainable development: A critical factor against rising global population and climate change

Sustainability is the only way forward for industry that does not lead to an environmental dead-end. Waste recycling has its place, but researchers in France suggest that from the outset the design of a product should consider the whole life cycle to offer any chance of sustainability.

7 Dec 2009

STERIS acts in response to FDA's recent notice on SYSTEM 1 Sterile Processing System

STERIS Corporation was notified on December 3, 2009 that the U.S. Food and Drug Administration (FDA) had issued a notice to healthcare facility administrators regarding the regulatory status of the STERIS SYSTEM 1® Sterile Processing System, as well as actions healthcare facilities should take if they use this device.

5 Dec 2009

Despite positive job market trends, economy continues to face challenges

Unemployment data released today by the U.S. Department of Labor indicates that although job losses have slowed significantly, the economy continues to face challenges, noted the Retail Industry Leaders Association (RILA).

5 Dec 2009

Manufacturing News and Research

Further Reading

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

Second-quarter fiscal 2010 results announced by Peregrine Pharmaceuticals

Nutraceutical International reports net income of $3.2M for fourth-quarter fiscal 2009

Fourth-quarter and full year fiscal 2009 results announced by Biodel

Urodynamix Technologies reviews strategic alternatives for sale of company's assets

Pacific Beach BioSciences signs licensing agreement with major pharmaceutical company

USPTO grants CyDex Pharmaceuticals patent for Captisol

Unigene Laboratories announces reduction in workforce and operating expenses

Nautilus enters into definitive agreements for sale of certain assets to Fit Dragon International

European market for digestive health ingredients to reach $536.5 million in 2015

First-quarter fiscal 2010 results announced by Helix BioPharma

Opinions: ARV access; global health promotion; climate change; under-nutrition; Ethiopia

Market for personalized medicine in the United States to grow 11 percent annually, shows report

ThermoGenesis enters into material transfer agreement with GID Group

La Jolla Pharmaceutical enters into definitive merger agreement with Adamis Pharmaceuticals

Adamis Pharmaceuticals to acquire La Jolla Pharmaceutical Company

Biolife Solutions, Centocor Research & Development sign license and cGMP manufacturing agreement

Sustainable development: A critical factor against rising global population and climate change

STERIS acts in response to FDA's recent notice on SYSTEM 1 Sterile Processing System

Despite positive job market trends, economy continues to face challenges

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy